HealSeq-A biomarker-based test that will drastically reduce time for the diagnosis and treatment of DR – TB from 4 months to 2 weeks.
Jaipur, March 24, 2022. Mumbai: India Health Fund (IHF), a collaborative initiative of Tata Trusts and The Global Fund to fight AIDS, Tuberculosis and Malaria today announced its support for HealSeq’s innovation …
HealSeq-A biomarker-based test that will drastically reduce time for the diagnosis and treatment of DR – TB from 4 months to 2 weeks. Read More